Aclaris Therapeutics, Inc.
ACRS
Revenue
2.77M
▲368.00k▲15.35%
3 Months ChangeAssets
161.07M
▼-12.99M▼-7.47%
3 Months ChangeLiabilities
27.25M
▼-4.80M▼-14.98%
3 Months ChangeFree Cash Flow
-20.95M
▲5.96M▲22.14%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 10-Q
ID: 0001558370-24-011376
2024-08-07
Form 8-K
ID: 0001558370-24-011201
2024-07-16
Form 8-K
ID: 0001558370-24-009853
2024-06-07
Form 8-K
ID: 0001558370-24-009009
2024-05-07
Form 10-Q
ID: 0001558370-24-007069
2024-05-07
Form 8-K
ID: 0001558370-24-007055
2024-03-19
Form 8-K
ID: 0001558370-24-003572
2024-02-27
Form 8-K
ID: 0001558370-24-001752
2024-02-05
Form 8-K
ID: 0001558370-24-000769
2024-01-19
Form 8-K
ID: 0001558370-24-000373